Clinical Trial Update: Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating vaginal isonicotinic acid hydrazide administration before insertion of a levonorgestrel-releasing intrauterine system.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception Complications
• Intrauterine Device Complications

Drugs mentioned

• Isonicotinic acid hydrazide (Isowned name not specified in snippet) (isonicotinic acid hydrazide)
• Levonorgestrel-Releasing Intrauterine System (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: Aswan University Hospital | Conditions: IUCD Complication | Phase 4 | Status: COMPLETED